• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II study.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Thatcher, Nick
    Dazzi, H
    Gosh, Anna K
    Johnson, Richard J
    Affiliation
    Christie Hospital & Paterson Institute of Cancer Research, Manchester, U.K.
    Issue Date
    1989-06
    
    Metadata
    Show full item record
    Citation
    Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II study. 1989, 16 Suppl A:49-52 Cancer Treat Rev
    Journal
    Cancer Treatment Reviews
    URI
    http://hdl.handle.net/10541/107643
    PubMed ID
    2788506
    Type
    Article
    Language
    en
    ISSN
    0305-7372
    Collections
    All Christie Publications
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study.
    • Authors: Thatcher N, Dazzi H, Johnson RJ, Russell S, Ghosh AK, Moore M, Chadwick G, Craig RD
    • Issue date: 1989 Nov
    • Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group study.
    • Authors: Whitehead RP, Kopecky KJ, Samson MK, Costanzi JJ, Natale RB, Feun LG, Hersh EM, Rinehart JJ
    • Issue date: 1991 Sep 4
    • Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study.
    • Authors: Stoter G, Shiloni E, Gundersen S, Cleton FJ, Iacobelli S, Bijman JT, Palmer P, Franks CR, Rodenhuis S
    • Issue date: 1989 Jun
    • Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.
    • Authors: Thatcher N, Dazzi H, Mellor M, Ghosh A, Carrington B, Johnson RJ, Loriaux EM, Craig RP
    • Issue date: 1990 Apr
    • Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.
    • Authors: Parkinson DR, Abrams JS, Wiernik PH, Rayner AA, Margolin KA, Van Echo DA, Sznol M, Dutcher JP, Aronson FR, Doroshow JH
    • Issue date: 1990 Oct
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.